The Significance of External Quality Assessment Schemes for Molecular Testing in Clinical Laboratories
- PMID: 35954349
- PMCID: PMC9367251
- DOI: 10.3390/cancers14153686
The Significance of External Quality Assessment Schemes for Molecular Testing in Clinical Laboratories
Abstract
External quality assessment (EQA) schemes are a tool for clinical laboratories to evaluate and manage the quality of laboratory practice with the support of an independent party (i.e., an EQA provider). Depending on the context, there are different types of EQA schemes available, as well as various EQA providers, each with its own field of expertise. In this review, an overview of the general requirements for EQA schemes and EQA providers based on international guidelines is provided. The clinical and scientific value of these kinds of schemes for clinical laboratories, clinicians and patients are highlighted, in addition to the support EQA can provide to other types of laboratories, e.g., laboratories affiliated to biotech companies. Finally, recent developments and challenges in laboratory medicine and quality management, for example, the introduction of artificial intelligence in the laboratory and the shift to a more individual-approach instead of a laboratory-focused approach, are discussed. EQA schemes should represent current laboratory practice as much as possible, which poses the need for EQA providers to introduce latest laboratory innovations in their schemes and to apply up-to-date guidelines. By incorporating these state-of-the-art techniques, EQA aims to contribute to continuous learning.
Keywords: external quality assessment; laboratory medicine; quality improvement.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Keppens C., Boone E., Gameiro P., Tack V., Moreau E., Hodges E., Evans P., Brüggemann M., Carter I., Lenze D., et al. Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect. Virchows Arch. 2021;479:365–376. doi: 10.1007/s00428-021-03046-0. - DOI - PMC - PubMed
-
- Tack V., Ligtenberg M.J.L., Tembuyser L., Normanno N., Vander Borght S., van Krieken H.J., Dequeker E.M. External Quality Assessment Unravels Interlaboratory Differences in Quality of RAS Testing for Anti-EGFR Therapy in Colorectal Cancer. Oncologist. 2015;20:257–262. doi: 10.1634/theoncologist.2014-0382. - DOI - PMC - PubMed
-
- Bellon E., Ligtenberg M.J., Tejpar S., Cox K., de Hertogh G., de Stricker K., Edsjö A., Gorgoulis V., Höfler G., Jung A., et al. External quality assessment for KRAS testing is needed: Setup of a European program and report of the first joined regional quality assessment rounds. Oncologist. 2011;16:467–478. doi: 10.1634/theoncologist.2010-0429. - DOI - PMC - PubMed
-
- WHO Overview of External Quality Assessment (EQA) [(accessed on 7 June 2022)]. Available online: https://cdn.who.int/media/docs/default-source/essential-medicines/norms-....
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
